Arax Advisory Partners’s Evotec EVO Stock Holding History

Arax Advisory Partners’s Portfolio EVO Stock Details EVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1	Closed	-$4	–	3971
2025 Q4	$4	Buy	+1	New	+$3	﹤0.01%	4062

Other funds holding EVO

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Arax Advisory Partners's EVO Position: Q1 2026 in Review

Arax Advisory Partners sold out of Evotec (EVO) in Q1 2026, closing a stake of 1 share — an estimated $4 sold.

Arax Advisory Partners first reported a position in EVO in Q4 2025 and held it in 1 quarter. The position peaked at $4 in Q4 2025. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

Arax Advisory Partners reported no remaining Evotec position as of Q1 2026 after selling out during the quarter.
Arax Advisory Partners sold 1 Evotec share in Q1 2026, an estimated $4.
Arax Advisory Partners first reported a position in Evotec in Q4 2025 and held it in 1 quarter.
Arax Advisory Partners's Evotec position peaked at $4 in Q4 2025.
46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.